Asthma drug improves motor function and strength in children with rare muscle diseases in small trial
Medical Xpress reports on a small trial from the University of Gothenburg in which 18 children and young people aged 6–16 with genetically confirmed congenital myopathy received oral salbutamol, an asthma drug, plus usual care or usual care alone for 24 weeks, then switched. Motor function scores averaged 3.61 points higher and dominant-hand grip strength rose by approximately 1.5 kilograms with salbutamol. Researchers say larger, longer studies are needed.
Why it matters: Relevant to rehabilitation clinicians and referring physicians who follow research on children and adolescents with congenital myopathies.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to medicalxpress.com. October 14, 2026.
